These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33866949)

  • 1. Downregulation of miR-125a-5p and miR-218-5p in Peripheral Blood Mononuclear Cells of Patients with Relapsing-Remitting Multiple Sclerosis.
    Mosarrezaii Aghdam A; Rezaei S; Zarza Nalivan F; Babaie F; Amiri Nikpour MR; Torkamandi S
    Immunol Invest; 2022 Jul; 51(5):1149-1161. PubMed ID: 33866949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of potential microRNA biomarkers for multiple sclerosis.
    Al-Temaimi R; Alshammari N; Alroughani R
    Exp Mol Pathol; 2024 Jun; 137():104903. PubMed ID: 38772208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential prognostic value of circulating inflamma-miR-146a-5p and miR-125a-5p in relapsing-remitting multiple sclerosis.
    Giuliani A; Lattanzi S; Ramini D; Graciotti L; Danni MC; Procopio AD; Silvestrini M; Olivieri F; Sabbatinelli J
    Mult Scler Relat Disord; 2021 Sep; 54():103126. PubMed ID: 34243103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplex Analysis of Cerebrospinal Fluid and Serum Exosomes MicroRNAs of Untreated Relapsing Remitting Multiple Sclerosis (RRMS) and Proposing Noninvasive Diagnostic Biomarkers.
    Mohammadinasr M; Montazersaheb S; Molavi O; Kahroba H; Talebi M; Ayromlou H; Hejazi MS
    Neuromolecular Med; 2023 Sep; 25(3):402-414. PubMed ID: 37020076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of mir-301a in PBMCs of patients with relapsing-remitting multiple sclerosis is associated with reduced NKRF and PIAS3 expression levels and disease activity.
    Tavakolpour V; Shokri G; Naser Moghadasi A; Mozafari Nahavandi P; Hashemi M; Kouhkan F
    J Neuroimmunol; 2018 Dec; 325():79-86. PubMed ID: 30316680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs Correlate with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder in a Chinese Population.
    Chen J; Zhu J; Wang Z; Yao X; Wu X; Liu F; Zheng W; Li Z; Lin A
    Med Sci Monit; 2017 May; 23():2565-2583. PubMed ID: 28550707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-132-3p, miR-106b-5p, and miR-19b-3p Are Associated with Brain-Derived Neurotrophic Factor Production and Clinical Activity in Multiple Sclerosis: A Pilot Study.
    Sağır F; Ersoy Tunalı N; Tombul T; Koral G; Çırak S; Yılmaz V; Türkoğlu R; Tüzün E
    Genet Test Mol Biomarkers; 2021 Nov; 25(11):720-726. PubMed ID: 34788141
    [No Abstract]   [Full Text] [Related]  

  • 8. Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis.
    Groen K; Maltby VE; Lea RA; Sanders KA; Fink JL; Scott RJ; Tajouri L; Lechner-Scott J
    BMC Med Genomics; 2018 May; 11(1):48. PubMed ID: 29783973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNA 106a-5p in cerebrospinal fluid as signature of early relapsing remitting multiple sclerosis: a cross sectional study.
    Zanghì A; Manuti V; Serviddio G; D'Amico E; Avolio C
    Front Immunol; 2023; 14():1226130. PubMed ID: 37711630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Potential Biomarkers in the Peripheral Blood Mononuclear Cells of Relapsing-Remitting Multiple Sclerosis Patients.
    Golabi M; Fathi F; Samadi M; Hesamian MS; Eskandari N
    Inflammation; 2022 Aug; 45(4):1815-1828. PubMed ID: 35347537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
    Honardoost MA; Kiani-Esfahani A; Ghaedi K; Etemadifar M; Salehi M
    Gene; 2014 Jul; 544(2):128-33. PubMed ID: 24792898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs expression in peripheral blood mononuclear cells of patients with multiple sclerosis propose.
    Abolghasemi M; Ali Ashrafi S; Asadi M; Shanehbandi D; Sadigh Etehad S; Poursaei E; Nejadghaderi SA; Shaafi S
    Mol Biol Rep; 2023 Jan; 50(1):167-172. PubMed ID: 36319782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptotic protease activating factor-1 gene and MicroRNA-484: A possible interplay in relapsing remitting multiple sclerosis.
    Mohamed DAW; Selim HM; Elmazny A; Genena A; Nabil MM
    Mult Scler Relat Disord; 2022 Feb; 58():103502. PubMed ID: 35030371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal microRNA signatures in multiple sclerosis reflect disease status.
    Ebrahimkhani S; Vafaee F; Young PE; Hur SSJ; Hawke S; Devenney E; Beadnall H; Barnett MH; Suter CM; Buckland ME
    Sci Rep; 2017 Oct; 7(1):14293. PubMed ID: 29084979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse correlation of expression of microRNA-140-5p with progression of multiple sclerosis and differentiation of encephalitogenic T helper type 1 cells.
    Guan H; Singh UP; Rao R; Mrelashvili D; Sen S; Hao H; Zumbrun EE; Singh NP; Nagarkatti PS; Nagarkatti M
    Immunology; 2016 Apr; 147(4):488-98. PubMed ID: 26780721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum miR-34a-5p, miR-103a-3p, and miR-376a-3p as possible biomarkers of conversion from relapsing-remitting to secondary progressive multiple sclerosis.
    Agostini S; Mancuso R; Citterio LA; Caputo D; Oreni L; Nuzzi R; Pasanisi MB; Rovaris M; Clerici M
    Neurobiol Dis; 2024 Oct; 200():106648. PubMed ID: 39181188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing-remitting multiple sclerosis patients.
    Arisi I; Malimpensa L; Manzini V; Brandi R; Gosetti di Sturmeck T; D'Amelio C; Crisafulli S; Ferrazzano G; Belvisi D; Malerba F; Florio R; Pascale E; Soreq H; Salvetti M; Cattaneo A; D'Onofrio M; Conte A
    Front Immunol; 2023; 14():1234869. PubMed ID: 38152407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing.
    Keller A; Leidinger P; Steinmeyer F; Stähler C; Franke A; Hemmrich-Stanisak G; Kappel A; Wright I; Dörr J; Paul F; Diem R; Tocariu-Krick B; Meder B; Backes C; Meese E; Ruprecht K
    Mult Scler; 2014 Mar; 20(3):295-303. PubMed ID: 23836875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis.
    Waschbisch A; Atiya M; Linker RA; Potapov S; Schwab S; Derfuss T
    PLoS One; 2011; 6(9):e24604. PubMed ID: 21949733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential microRNA expression in blood in multiple sclerosis.
    Søndergaard HB; Hesse D; Krakauer M; Sørensen PS; Sellebjerg F
    Mult Scler; 2013 Dec; 19(14):1849-57. PubMed ID: 23773985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.